{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:37:37Z","timestamp":1792651057792,"version":"4.5.0"},"reference-count":190,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPD"],"published-print":{"date-parts":[[2021,10,12]]},"abstract":"<jats:p>Parkinson\u2019s disease (PD) is the second most common neurodegenerative disease worldwide, characterized by symptoms of bradykinesia, rigidity, postural instability, and tremor. Recently, there has been a growing focus on the relationship between the gut and the development of PD. Emerging to the forefront, an interesting concept has developed suggesting that the initial pathophysiological changes occur in the gastrointestinal tract before changes are seen within the brain. This review is aimed at highlighting the relationship between PD and the gastrointestinal tract, along with the supporting evidence for this. Firstly, we will focus on the gastrointestinal conditions and symptoms which commonly affects patients, including both upper and lower gastrointestinal issues. Secondly, the impact of nutrition and diet on neurological health and PD physiology, with particular emphasis on commonly consumed items including macronutrients and micronutrients. Finally, variability of the gut microbiome will also be discussed and its link with both the symptoms and signs of PD. The evidence presented in this review highly suggests that the initial pathogenesis in the gut may proceed the development of prodromal PD subtypes, and therefore building on this further could be imperative and lead to earlier diagnosis with new and improved therapeutics.<\/jats:p>","DOI":"10.3233\/jpd-212707","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T05:28:59Z","timestamp":1625635739000},"page":"1491-1505","source":"Crossref","is-referenced-by-count":50,"title":["Parkinson\u2019s Disease and the Gut: Symptoms, Nutrition, and Microbiota"],"prefix":"10.1177","volume":"11","author":[{"given":"Nehal","family":"Yemula","sequence":"first","affiliation":[{"name":"Norfolk and Norwich University Hospital, Norwich, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celina","family":"Dietrich","sequence":"additional","affiliation":[{"name":"Faculty of Health and Medical Sciences, University of East Anglia, Norwich, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaclav","family":"Dostal","sequence":"additional","affiliation":[{"name":"Norfolk and Norwich University Hospital, Norwich, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hornberger","sequence":"additional","affiliation":[{"name":"Faculty of Health and Medical Sciences, University of East Anglia, Norwich, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JPD-212707_ref1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000275491","article-title":"Geographic and ethnic variation in Parkinson disease: A population-based study of US Medicare beneficiaries","volume":"34","author":"Wright Willis","year":"2010","journal-title":"Neuroepidemiology"},{"key":"10.3233\/JPD-212707_ref2","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.clinph.2008.03.017","article-title":"Pathophysiology of parkinsonism","volume":"119","author":"Galvan","year":"2008","journal-title":"Clin Neurophysiol"},{"key":"10.3233\/JPD-212707_ref3","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/brain\/aww230","article-title":"Like prions: The propagation of aggregated tau and alpha-synuclein in neurodegeneration","volume":"140","author":"Goedert","year":"2017","journal-title":"Brain"},{"key":"10.3233\/JPD-212707_ref4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2051-5960-1-2","article-title":"The prion hypothesis in Parkinson\u2019s disease: Braak to the future","volume":"1","author":"Visanji","year":"2013","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JPD-212707_ref5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.neubiorev.2016.07.010","article-title":"Motor symptoms in Parkinson\u2019s disease: A unified framework","volume":"68","author":"Moustafa","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"key":"10.3233\/JPD-212707_ref6","first-page":"504","article-title":"Parkinson\u2019s disease and its management: Part 1: Disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis","volume":"40","author":"DeMaagd","year":"2015","journal-title":"P T"},{"key":"10.3233\/JPD-212707_ref7","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"10.3233\/JPD-212707_ref8","doi-asserted-by":"crossref","first-page":"4518023","DOI":"10.1155\/2020\/4518023","article-title":"Minireview on the relations between gut microflora and Parkinson\u2019s disease: Further biochemical (oxidative stress), inflammatory, and neurological particularities","volume":"2020","author":"Ilie","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"10.3233\/JPD-212707_ref9","first-page":"26191","article-title":"Dysbiosis of the gut microbiota in disease","volume":"26","author":"Carding","year":"2015","journal-title":"Microb Ecol Health Dis"},{"key":"10.3233\/JPD-212707_ref10","first-page":"4730539","article-title":"Gut microbiota in Alzheimer\u2019s disease, depression, and type 2 diabetes mellitus: The role of oxidative stress","volume":"2019","author":"Luca","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"10.3233\/JPD-212707_ref11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3389\/fnins.2019.00369","article-title":"Alpha-synuclein pathology and the role of the microbiota in Parkinson\u2019s disease","volume":"13","author":"Fitzgerald","year":"2019","journal-title":"Front Neurosci"},{"key":"10.3233\/JPD-212707_ref12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41531-021-00156-z","article-title":"Meta-analysis of the Parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation","volume":"7","author":"Romano","year":"2021","journal-title":"NPJ Parkinsons Dis"},{"key":"10.3233\/JPD-212707_ref13","doi-asserted-by":"crossref","first-page":"S297","DOI":"10.3233\/JPD-191711","article-title":"Increasing comparability and utility of gut microbiome studies in Parkinson\u2019s disease: A systematic review","volume":"9","author":"Boertien","year":"2019","journal-title":"J Parkinsons Dis"},{"key":"10.3233\/JPD-212707_ref14","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","article-title":"Parkinson\u2019s disease: A dual-hit hypothesis","volume":"33","author":"Hawkes","year":"2007","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JPD-212707_ref15","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1749-6632.2009.04365.x","article-title":"Parkinson\u2019s disease: The dual hit theory revisited","volume":"1170","author":"Hawkes","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.3233\/JPD-212707_ref16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/B978-0-444-63945-5.00017-9","article-title":"Prion-like propagation of pathology in Parkinson disease","volume":"153","author":"Volpicelli-Daley","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"10.3233\/JPD-212707_ref17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fneur.2017.00037","article-title":"Exploring Braak\u2019s hypothesis of Parkinson\u2019s disease","volume":"8","author":"Rietdijk","year":"2017","journal-title":"Front Neurol"},{"key":"10.3233\/JPD-212707_ref18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-1-4939-0897-4_3","article-title":"The enteric nervous system and gastrointestinal innervation: Integrated local and central control","volume":"817","author":"Furness","year":"2014","journal-title":"Adv Exp Med Biol"},{"key":"10.3233\/JPD-212707_ref19","first-page":"iv15","article-title":"Anatomy and physiology of the enteric nervous system","volume":"47 Suppl 4","author":"Costa","year":"2000","journal-title":"Gut"},{"key":"10.3233\/JPD-212707_ref20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fpsyt.2018.00044","article-title":"Vagus nerve as modulator of the brain-gut axis in psychiatric and inflammatory disorders","volume":"9","author":"Breit","year":"2018","journal-title":"Front Psychiatry"},{"key":"10.3233\/JPD-212707_ref21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JPD-212707_ref22","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.bbadis.2008.07.006","article-title":"A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders","volume":"1792","author":"Jellinger","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl","key":"10.3233\/JPD-212707_ref23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1679\/aohc.52.Suppl_191","article-title":"Lewy bodies in the enteric nervous system in Parkinson\u2019s disease","volume":"52","author":"Wakabayashi","year":"1989","journal-title":"Arch Histol Cytol"},{"key":"10.3233\/JPD-212707_ref24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","article-title":"Gastric alpha-synuclein immunoreactive inclusions in Meissner\u2019s and Auerbach\u2019s plexuses in cases staged for Parkinson\u2019s disease-related brain pathology","volume":"396","author":"Braak","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.3233\/JPD-212707_ref25","doi-asserted-by":"crossref","first-page":"e12728","DOI":"10.1371\/journal.pone.0012728","article-title":"Colonic biopsies to assess the neuropathology of Parkinson\u2019s disease and its relationship with symptoms","volume":"5","author":"Lebouvier","year":"2010","journal-title":"PLoS One"},{"key":"10.3233\/JPD-212707_ref26","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/mds.25776","article-title":"Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders","volume":"29","author":"Gelpi","year":"2014","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-212707_ref27","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2990.2006.00727.x","article-title":"Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects","volume":"32","author":"Bloch","year":"2006","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JPD-212707_ref28","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(95)92707-7","article-title":"Dopaminergic defect of enteric nervous system in Parkinson\u2019s disease patients with chronic constipation","volume":"346","author":"Singaram","year":"1995","journal-title":"Lancet"},{"key":"10.3233\/JPD-212707_ref29","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.nbd.2011.08.014","article-title":"A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson\u2019s disease","volume":"45","author":"Pouclet","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JPD-212707_ref30","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/mds.25988","article-title":"In vivo gastric detection of alpha-synuclein inclusions in Parkinson\u2019s disease","volume":"30","author":"Sanchez-Ferro","year":"2015","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-212707_ref31","doi-asserted-by":"crossref","first-page":"e11337","DOI":"10.1097\/MD.0000000000011337","article-title":"Gastrointestinal nervous system alpha-synuclein as a potential biomarker of Parkinson disease","volume":"97","author":"Yan","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.3233\/JPD-212707_ref32","doi-asserted-by":"crossref","first-page":"469","DOI":"10.5056\/jnm17141","article-title":"Relation of enteric alpha-synuclein to gastrointestinal dysfunction in patients with Parkinson\u2019s disease and in neurologically intact subjects","volume":"24","author":"Lee","year":"2018","journal-title":"J Neurogastroenterol Motil"},{"key":"10.3233\/JPD-212707_ref33","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.24648","article-title":"Pathological alpha-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients","volume":"79","author":"Stokholm","year":"2016","journal-title":"Ann Neurol"},{"key":"10.3233\/JPD-212707_ref34","doi-asserted-by":"crossref","first-page":"eaar5280","DOI":"10.1126\/scitranslmed.aar5280","article-title":"The vermiform appendix impacts the risk of developing Parkinson\u2019s disease","volume":"10","author":"Killinger","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.3233\/JPD-212707_ref35","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3389\/fneur.2020.00510","article-title":"Appendectomy, tonsillectomy and Parkinson\u2019s disease risk: A Swedish register-based study","volume":"11","author":"Liu","year":"2020","journal-title":"Front Neurol"},{"key":"10.3233\/JPD-212707_ref36","doi-asserted-by":"publisher","DOI":"10.1177\/0003134821989034"},{"key":"10.3233\/JPD-212707_ref37","doi-asserted-by":"crossref","first-page":"e425","DOI":"10.1111\/j.1365-2982.2012.01974.x","article-title":"Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation","volume":"24","author":"Wang","year":"2012","journal-title":"Neurogastroenterol Motil"},{"key":"10.3233\/JPD-212707_ref38","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.nbd.2012.04.009","article-title":"alpha-Synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficits","volume":"47","author":"Hallett","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JPD-212707_ref39","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00401-010-0665-2","article-title":"Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson\u2019s disease","volume":"119","author":"Del Tredici","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JPD-212707_ref40","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/mds.20342","article-title":"Swallowing abnormalities and dyskinesia in Parkinson\u2019s disease","volume":"20","author":"Monte","year":"2005","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-212707_ref41","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1212\/WNL.0000000000003961","article-title":"Vagotomy and Parkinson disease: A Swedish register-based matched-cohort study","volume":"88","author":"Liu","year":"2017","journal-title":"Neurology"},{"key":"10.3233\/JPD-212707_ref42","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ana.24448","article-title":"Vagotomy and subsequent risk of Parkinson\u2019s disease","volume":"78","author":"Svensson","year":"2015","journal-title":"Ann Neurol"},{"key":"10.3233\/JPD-212707_ref43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-008-0406-y","article-title":"A critical reappraisal of current staging of Lewy-related pathology in human brain","volume":"116","author":"Jellinger","year":"2008","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JPD-212707_ref44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13195-014-0073-2","article-title":"Alpha-synuclein biology in Lewy body diseases","volume":"6","author":"Kim","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JPD-212707_ref45","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","article-title":"Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders","volume":"119","author":"Beach","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JPD-212707_ref46","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.nbd.2012.09.007","article-title":"Colonic inflammation in Parkinson\u2019s disease","volume":"50","author":"Devos","year":"2013","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JPD-212707_ref47","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00401-008-0344-8","article-title":"The progression of pathology in longitudinally followed patients with Parkinson\u2019s disease","volume":"115","author":"Halliday","year":"2008","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JPD-212707_ref48","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1046\/j.1460-9568.2002.02301.x","article-title":"Aggresome-related biogenesis of Lewy bodies","volume":"16","author":"McNaught","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.3233\/JPD-212707_ref49","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1074\/jbc.M310994200","article-title":"Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective","volume":"279","author":"Tanaka","year":"2004","journal-title":"J Biol Chem"},{"key":"10.3233\/JPD-212707_ref50","doi-asserted-by":"crossref","first-page":"593822","DOI":"10.3389\/fphar.2020.593822","article-title":"Editorial: Non-dopaminergic systems in Parkinson\u2019s disease","volume":"11","author":"Miguelez","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.3233\/JPD-212707_ref51","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s13311-013-0239-9","article-title":"Treatment of Parkinson\u2019s disease: What\u2019s in the non-dopaminergic pipeline?","volume":"11","author":"Hung","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.3233\/JPD-212707_ref52","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/ene.13398","article-title":"More than constipation - bowel symptoms in Parkinson\u2019s disease and their connection to gut microbiota","volume":"24","author":"Mertsalmi","year":"2017","journal-title":"Eur J Neurol"},{"key":"10.3233\/JPD-212707_ref53","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00702-015-1442-0","article-title":"Small intestine dysfunction in Parkinson\u2019s disease","volume":"122","author":"Dutkiewicz","year":"2015","journal-title":"J Neural Transm (Vienna)"},{"key":"10.3233\/JPD-212707_ref54","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41598-017-16790-8","article-title":"Parkinson disease with constipation: Clinical features and relevant factors","volume":"8","author":"Yu","year":"2018","journal-title":"Sci Rep"},{"key":"10.3233\/JPD-212707_ref55","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/mds.25445","article-title":"Prodromal autonomic symptoms and signs in Parkinson\u2019s disease and dementia with Lewy bodies","volume":"28","author":"Postuma","year":"2013","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-212707_ref56","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1212\/WNL.57.3.456","article-title":"Frequency of bowel movements and the future risk of Parkinson\u2019s disease","volume":"57","author":"Abbott","year":"2001","journal-title":"Neurology"},{"key":"10.3233\/JPD-212707_ref57","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1053\/j.gastro.2019.12.034","article-title":"Mechanisms, evaluation, and management of chronic constipation","volume":"158","author":"Bharucha","year":"2020","journal-title":"Gastroenterology"},{"key":"10.3233\/JPD-212707_ref58","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2165\/00002512-199710040-00002","article-title":"Gastrointestinal motility problems in patients with Parkinson\u2019s disease. Effects of antiparkinsonian treatment and guidelines for management","volume":"10","author":"Jost","year":"1997","journal-title":"Drugs Aging"},{"key":"10.3233\/JPD-212707_ref59","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1474-4422(03)00307-7","article-title":"Gastrointestinal dysfunction in Parkinson\u2019s disease","volume":"2","author":"Pfeiffer","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.3233\/JPD-212707_ref60","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/mds.870100519","article-title":"Anorectal function in fluctuating (on-off) Parkinson\u2019s disease: Evaluation by combined anorectal manometry and electromyography","volume":"10","author":"Ashraf","year":"1995","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-212707_ref61","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/mds.870090612","article-title":"Anorectal manometry in the assessment of anorectal function in Parkinson\u2019s disease: A comparison with chronic idiopathic constipation","volume":"9","author":"Ashraf","year":"1994","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-212707_ref62","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00004836-199407000-00004","article-title":"Gastrointestinal dysfunction in Parkinson\u2019s disease. A report of clinical experience at a single center","volume":"19","author":"Byrne","year":"1994","journal-title":"J Clin Gastroenterol"},{"key":"10.3233\/JPD-212707_ref63","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/gutjnl-2017-315666","article-title":"Inflammatory bowel disease increases the risk of Parkinson\u2019s disease: A Danish nationwide cohort study 1977-2014","volume":"68","author":"Villumsen","year":"2019","journal-title":"Gut"},{"key":"10.3233\/JPD-212707_ref64","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ibd\/izy190","article-title":"Inflammatory bowel disease and Parkinson\u2019s disease: A nationwide Swedish cohort study","volume":"25","author":"Weimers","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.3233\/JPD-212707_ref65","doi-asserted-by":"crossref","first-page":"6455","DOI":"10.1111\/j.1742-4658.2009.07344.x","article-title":"LRRK2 in Parkinson\u2019s disease: Genetic and clinical studies from patients","volume":"276","author":"Kumari","year":"2009","journal-title":"FEBS J"},{"key":"10.3233\/JPD-212707_ref66","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/pmj.76.895.273","article-title":"Role of smoking in inflammatory bowel disease: Implications for therapy","volume":"76","author":"Thomas","year":"2000","journal-title":"Postgrad Med J"},{"key":"10.3233\/JPD-212707_ref67","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.archger.2015.08.004","article-title":"Association between cigarette smoking and Parkinson\u2019s disease: A meta-analysis","volume":"61","author":"Li","year":"2015","journal-title":"Arch Gerontol Geriatr"},{"key":"10.3233\/JPD-212707_ref68","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/mds.25882","article-title":"Gut feelings about smoking and coffee in Parkinson\u2019s disease","volume":"29","author":"Derkinderen","year":"2014","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-212707_ref69","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/PL00009546","article-title":"Esophageal manometric abnormalities in Parkinson\u2019s disease","volume":"13","author":"Bassotti","year":"1998","journal-title":"Dysphagia"},{"key":"10.3233\/JPD-212707_ref70","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/mds.22841","article-title":"Real-time visualization of altered gastric motility by magnetic resonance imaging in patients with Parkinson\u2019s disease","volume":"25","author":"Unger","year":"2010","journal-title":"Mov Disord"},{"issue":"Suppl 3","key":"10.3233\/JPD-212707_ref71","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00415-009-5240-1","article-title":"Non-motor symptoms in Parkinson\u2019s disease","volume":"256","author":"Park","year":"2009","journal-title":"J Neurol"},{"issue":"Suppl 2","key":"10.3233\/JPD-212707_ref72","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/00207454.2011.620196","article-title":"Nonmotor symptoms in Parkinson\u2019s disease","volume":"121","author":"Stacy","year":"2011","journal-title":"Int J Neurosci"},{"key":"10.3233\/JPD-212707_ref73","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.parkreldis.2011.12.004","article-title":"Gastroparesis and Parkinson\u2019s disease: A systematic review","volume":"18","author":"Heetun","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-212707_ref74","first-page":"112","article-title":"Small intestinal bacterial overgrowth: A comprehensive review","volume":"3","author":"Dukowicz","year":"2007","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.3233\/JPD-212707_ref75","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00455-015-9671-9","article-title":"Dysphagia in Parkinson\u2019s disease","volume":"31","author":"Suttrup","year":"2016","journal-title":"Dysphagia"},{"key":"10.3233\/JPD-212707_ref76","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1053\/gast.1996.v110.pm8566584","article-title":"Mechanisms of oral-pharyngeal dysphagia in patients with Parkinson\u2019s disease","volume":"110","author":"Ali","year":"1996","journal-title":"Gastroenterology"},{"key":"10.3233\/JPD-212707_ref77","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.parkreldis.2011.11.006","article-title":"Prevalence of oropharyngeal dysphagia in Parkinson\u2019s disease: A meta-analysis","volume":"18","author":"Kalf","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-212707_ref78","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00401-020-02233-8","article-title":"Lewy pathology of the esophagus correlates with the progression of Lewy body disease: A Japanese cohort study of autopsy cases","volume":"141","author":"Tanei","year":"2021","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JPD-212707_ref79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/dote\/dow038","article-title":"Clinical and manometric characteristics of patients with Parkinson\u2019s disease and esophageal symptoms","volume":"30","author":"Su","year":"2017","journal-title":"Dis Esophagus"},{"key":"10.3233\/JPD-212707_ref80","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1212\/WNL.39.10.1309","article-title":"Swallowing abnormalities and their response to treatment in Parkinson\u2019s disease","volume":"39","author":"Bushmann","year":"1989","journal-title":"Neurology"},{"key":"10.3233\/JPD-212707_ref81","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1353-8020(03)00045-2","article-title":"Swallowing disorders in Parkinson\u2019s disease","volume":"9","author":"Potulska","year":"2003","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-212707_ref82","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/NEN.0b013e3182965886","article-title":"Parkinson disease affects peripheral sensory nerves in the pharynx","volume":"72","author":"Mu","year":"2013","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JPD-212707_ref83","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.TGR.0000318899.87690.44","article-title":"Speech and swallowing in Parkinson\u2019s disease","volume":"24","author":"Tjaden","year":"2008","journal-title":"Top Geriatr Rehabil"},{"key":"10.3233\/JPD-212707_ref84","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/WCO.0000000000000112","article-title":"Premotor and nonmotor features of Parkinson\u2019s disease","volume":"27","author":"Goldman","year":"2014","journal-title":"Curr Opin Neurol"},{"key":"10.3233\/JPD-212707_ref85","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.parkreldis.2014.08.013","article-title":"Drooling in Parkinson\u2019s disease: A review","volume":"20","author":"Srivanitchapoom","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-212707_ref86","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/mds.23720","article-title":"Pathophysiology of diurnal drooling in Parkinson\u2019s disease","volume":"26","author":"Kalf","year":"2011","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-212707_ref87","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.parkreldis.2007.12.007","article-title":"Is silent aspiration a risk factor for respiratory infection in Parkinson\u2019s disease patients?","volume":"14","author":"Nobrega","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-212707_ref88","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/ana.10381","article-title":"Diet and Parkinson\u2019s disease: A potential role of dairy products in men","volume":"52","author":"Chen","year":"2002","journal-title":"Ann Neurol"},{"key":"10.3233\/JPD-212707_ref89","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12915-020-00775-7","article-title":"Parkinson\u2019s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions","volume":"18","author":"Baldini","year":"2020","journal-title":"BMC Biol"},{"key":"10.3233\/JPD-212707_ref90","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3390\/nu11020416","article-title":"The impact of caffeine and coffee on human health","volume":"11","author":"Cornelis","year":"2019","journal-title":"Nutrients"},{"key":"10.3233\/JPD-212707_ref91","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ana.1052","article-title":"Prospective study of caffeine consumption and risk of Parkinson\u2019s disease in men and women","volume":"50","author":"Ascherio","year":"2001","journal-title":"Ann Neurol"},{"key":"10.3233\/JPD-212707_ref92","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.3390\/nu12061860","article-title":"The effect of caffeine on the risk and progression of Parkinson\u2019s disease: A meta-analysis","volume":"12","author":"Hong","year":"2020","journal-title":"Nutrients"},{"key":"10.3233\/JPD-212707_ref93","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/1531-8257(199901)14:1<28::AID-MDS1007>3.0.CO;2-O","article-title":"Nutritional and occupational factors influencing the risk of Parkinson\u2019s disease: A case-control study in southeastern Sweden","volume":"14","author":"Fall","year":"1999","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-212707_ref94","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.pneurobio.2007.05.001","article-title":"Adenosine A2A receptors and basal ganglia physiology","volume":"83","author":"Schiffmann","year":"2007","journal-title":"Prog Neurobiol"},{"key":"10.3233\/JPD-212707_ref95","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11302-008-9100-8","article-title":"Adenosine A(2A) receptors in Parkinson\u2019s disease treatment","volume":"4","author":"Cieslak","year":"2008","journal-title":"Purinergic Signal"},{"key":"10.3233\/JPD-212707_ref96","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s11064-011-0682-0","article-title":"Role of secondary mediators in caffeine-mediated neuroprotection in maneb- and paraquat-induced Parkinson\u2019s disease phenotype in the mouse","volume":"37","author":"Yadav","year":"2012","journal-title":"Neurochem Res"},{"key":"10.3233\/JPD-212707_ref97","doi-asserted-by":"crossref","first-page":"RC143","DOI":"10.1523\/JNEUROSCI.21-10-j0001.2001","article-title":"Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson\u2019s disease","volume":"21","author":"Chen","year":"2001","journal-title":"J Neurosci"},{"key":"10.3233\/JPD-212707_ref98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07315724.2009.10719754","article-title":"Parkinson\u2019s disease and tea: A quantitative review","volume":"28","author":"Barranco Quintana","year":"2009","journal-title":"J Am Coll Nutr"},{"key":"10.3233\/JPD-212707_ref99","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000026273","article-title":"Parkinson\u2019s disease and environmental factors. Matched case-control study in the Limousin region, France","volume":"19","author":"Preux","year":"2000","journal-title":"Neuroepidemiology"},{"key":"10.3233\/JPD-212707_ref100","doi-asserted-by":"crossref","first-page":"923464","DOI":"10.1100\/2012\/923464","article-title":"A meta-analysis of tea drinking and risk of Parkinson\u2019s disease","volume":"2012","author":"Li","year":"2012","journal-title":"ScientificWorldJournal"},{"key":"10.3233\/JPD-212707_ref101","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/ggi.12123","article-title":"Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson\u2019s disease","volume":"14","author":"Qi","year":"2014","journal-title":"Geriatr Gerontol Int"},{"key":"10.3233\/JPD-212707_ref102","first-page":"31","article-title":"Tea consumption and risk of Parkinson\u2019s disease: A meta-analysis","volume":"24","author":"Zhen","year":"2019","journal-title":"Neurology Asia"},{"key":"10.3233\/JPD-212707_ref103","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1093\/jn\/130.10.2409","article-title":"Effects of tea consumption on nutrition and health","volume":"130","author":"Yang","year":"2000","journal-title":"J Nutr"},{"key":"10.3233\/JPD-212707_ref104","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/jnr.20315","article-title":"(\u2013)-Epigallocatechin gallate inhibits lipopolysaccharide-induced microglial activation and protects against inflammation-mediated dopaminergic neuronal injury","volume":"78","author":"Li","year":"2004","journal-title":"J Neurosci Res"},{"key":"10.3233\/JPD-212707_ref105","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.neuro.2008.03.004","article-title":"Protective effect of the green tea component, L-theanine on environmental toxins-induced neuronal cell death","volume":"29","author":"Cho","year":"2008","journal-title":"Neurotoxicology"},{"key":"10.3233\/JPD-212707_ref106","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/aje\/155.8.732","article-title":"Parkinson\u2019s disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake","volume":"155","author":"Checkoway","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.3233\/JPD-212707_ref107","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1017\/S0007114512000955","article-title":"A cohort study on diet and the risk of Parkinson\u2019s disease: The role of food groups and diet quality","volume":"109","author":"Saaksjarvi","year":"2013","journal-title":"Br J Nutr"},{"key":"10.3233\/JPD-212707_ref108","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10654-012-9760-0","article-title":"Dietary and lifestyle variables in relation to incidence of Parkinson\u2019s disease in Greece","volume":"28","author":"Kyrozis","year":"2013","journal-title":"Eur J Epidemiol"},{"key":"10.3233\/JPD-212707_ref109","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10654-014-9921-4","article-title":"Dairy foods intake and risk of Parkinson\u2019s disease: A dose-response meta-analysis of prospective cohort studies","volume":"29","author":"Jiang","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"10.3233\/JPD-212707_ref110","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.0000000000004057","article-title":"Intake of dairy foods and risk of Parkinson disease","volume":"89","author":"Hughes","year":"2017","journal-title":"Neurology"},{"key":"10.3233\/JPD-212707_ref111","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/aje\/kwm127","article-title":"Plasma urate and risk of Parkinson\u2019s disease","volume":"166","author":"Weisskopf","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.3233\/JPD-212707_ref112","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/mds.22139","article-title":"Uric acid in Parkinson\u2019s disease","volume":"23","author":"Schlesinger","year":"2008","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-212707_ref113","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1017\/S0317167100012981","article-title":"Serum urate and the risk of Parkinson\u2019s disease: Results from a meta-analysis","volume":"40","author":"Shen","year":"2013","journal-title":"Can J Neurol Sci"},{"key":"10.3233\/JPD-212707_ref114","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/aje\/kwm385","article-title":"Diet, urate, and Parkinson\u2019s disease risk in men","volume":"167","author":"Gao","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.3233\/JPD-212707_ref115","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/ajcn\/86.5.1486","article-title":"Prospective study of dietary pattern and risk of Parkinson disease","volume":"86","author":"Gao","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.3233\/JPD-212707_ref116","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s13668-018-0222-5","article-title":"Mediterranean diet in preventing neurodegenerative diseases","volume":"7","author":"Gardener","year":"2018","journal-title":"Curr Nutr Rep"},{"key":"10.3233\/JPD-212707_ref117","doi-asserted-by":"crossref","first-page":"a1344","DOI":"10.1136\/bmj.a1344","article-title":"Adherence to Mediterranean diet and health status: Meta-analysis","volume":"337","author":"Sofi","year":"2008","journal-title":"BMJ"},{"key":"10.3233\/JPD-212707_ref118","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neulet.2016.11.007","article-title":"Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson\u2019s disease: A meta-analysis","volume":"636","author":"Xie","year":"2017","journal-title":"Neurosci Lett"},{"key":"10.3233\/JPD-212707_ref119","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.3390\/nu7095333","article-title":"Associations between B vitamins and Parkinson\u2019s disease","volume":"7","author":"Shen","year":"2015","journal-title":"Nutrients"},{"key":"10.3233\/JPD-212707_ref120","doi-asserted-by":"crossref","first-page":"672838","DOI":"10.1155\/2015\/672838","article-title":"Dietary factors in the etiology of Parkinson\u2019s disease","volume":"2015","author":"Agim","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.3233\/JPD-212707_ref121","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1212\/WNL.62.4.676","article-title":"Effect of L-dopa on plasma homocysteine in PD patients: Relationship to B-vitamin status","volume":"62","author":"Schroecksnadel","year":"2004","journal-title":"Neurology"},{"key":"10.3233\/JPD-212707_ref122","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S1474-4422(05)70097-1","article-title":"Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson\u2019s disease: A meta-analysis","volume":"4","author":"Etminan","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.3233\/JPD-212707_ref123","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3389\/fneur.2020.00454","article-title":"A review of the relationship between vitamin D and Parkinson disease symptoms","volume":"11","author":"Fullard","year":"2020","journal-title":"Front Neurol"},{"key":"10.3233\/JPD-212707_ref124","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3945\/ajcn.112.051664","article-title":"Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease","volume":"97","author":"Suzuki","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"10.3233\/JPD-212707_ref125","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3389\/fneur.2018.00909","article-title":"Association between serum vitamin D levels and Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"9","author":"Luo","year":"2018","journal-title":"Front Neurol"},{"key":"10.3233\/JPD-212707_ref126","doi-asserted-by":"crossref","first-page":"e895","DOI":"10.1212\/WNL.0000000000011373","article-title":"Dietary antioxidants and the risk of Parkinson disease: The Swedish National March Cohort","volume":"96","author":"Hantikainen","year":"2021","journal-title":"Neurology"},{"key":"10.3233\/JPD-212707_ref127","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.4103\/1673-5374.262599","article-title":"Relationship between high dietary fat intake and Parkinson\u2019s disease risk: A meta-analysis","volume":"14","author":"Qu","year":"2019","journal-title":"Neural Regen Res"},{"key":"10.3233\/JPD-212707_ref128","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1212\/01.WNL.0000166038.67153.9F","article-title":"Dietary fatty acids and the risk of Parkinson disease: The Rotterdam study","volume":"64","author":"de Lau","year":"2005","journal-title":"Neurology"},{"key":"10.3233\/JPD-212707_ref129","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrn3820","article-title":"Polyunsaturated fatty acids and their metabolites in brain function and disease","volume":"15","author":"Bazinet","year":"2014","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JPD-212707_ref130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11745-999-0350-3","article-title":"Effects of dietary polyunsaturated fatty acids on neuronal function","volume":"34","author":"Fernstrom","year":"1999","journal-title":"Lipids"},{"key":"10.3233\/JPD-212707_ref131","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.parkreldis.2013.09.023","article-title":"Dietary fat intake, pesticide use, and Parkinson\u2019s disease","volume":"20","author":"Kamel","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-212707_ref132","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00008877-200609000-00009","article-title":"Neuroprotective and disease-modifying effects of the ketogenic diet","volume":"17","author":"Gasior","year":"2006","journal-title":"Behav Pharmacol"},{"key":"10.3233\/JPD-212707_ref133","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1212\/01.WNL.0000152046.11390.45","article-title":"Treatment of Parkinson disease with diet-induced hyperketonemia: A feasibility study","volume":"64","author":"Vanitallie","year":"2005","journal-title":"Neurology"},{"key":"10.3233\/JPD-212707_ref134","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3389\/fnagi.2017.00206","article-title":"Protein-restricted diets for ameliorating motor fluctuations in Parkinson\u2019s disease","volume":"9","author":"Wang","year":"2017","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JPD-212707_ref135","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/ggi.12321","article-title":"Macronutrients intake and risk of Parkinson\u2019s disease: A meta-analysis","volume":"15","author":"Wang","year":"2015","journal-title":"Geriatr Gerontol Int"},{"key":"10.3233\/JPD-212707_ref136","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/ajcn\/77.1.128","article-title":"Effects of normal meals rich in carbohydrates or proteins on plasma tryptophan and tyrosine ratios","volume":"77","author":"Wurtman","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.3233\/JPD-212707_ref137","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.nut.2009.05.021","article-title":"Dietary glycemic index is inversely associated with the risk of Parkinson\u2019s disease: A case-control study in Japan","volume":"26","author":"Murakami","year":"2010","journal-title":"Nutrition"},{"key":"10.3233\/JPD-212707_ref138","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/mds.27390","article-title":"Low-fat versus ketogenic diet in Parkinson\u2019s disease: A pilot randomized controlled trial","volume":"33","author":"Phillips","year":"2018","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-212707_ref139","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3390\/nu9040322","article-title":"Impact of high-carbohydrate diet on metabolic parameters in patients with type 2 diabetes","volume":"9","author":"Jung","year":"2017","journal-title":"Nutrients"},{"key":"10.3233\/JPD-212707_ref140","first-page":"4951379","article-title":"Analysis of the relationship between type ii diabetes mellitus and Parkinson\u2019s disease: A systematic review","volume":"2019","author":"Camargo Maluf","year":"2019","journal-title":"Parkinsons Dis"},{"key":"10.3233\/JPD-212707_ref141","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/S0140-6736(17)31585-4","article-title":"Exenatide once weekly versus placebo in Parkinson\u2019s disease: A randomised, double-blind, placebo-controlled trial","volume":"390","author":"Athauda","year":"2017","journal-title":"Lancet"},{"key":"10.3233\/JPD-212707_ref142","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/jnr.21483","article-title":"Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson\u2019s disease","volume":"86","author":"Bertilsson","year":"2008","journal-title":"J Neurosci Res"},{"key":"10.3233\/JPD-212707_ref143","first-page":"17","article-title":"Part 1: The human gut microbiome in health and disease","volume":"13","author":"Bull","year":"2014","journal-title":"Integr Med (Encinitas)"},{"key":"10.3233\/JPD-212707_ref144","doi-asserted-by":"crossref","first-page":"23129","DOI":"10.1038\/srep23129","article-title":"Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid","volume":"6","author":"Collado","year":"2016","journal-title":"Sci Rep"},{"key":"10.3233\/JPD-212707_ref145","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/0004867415569801","article-title":"Pathways in gut-brain communication: Evidence for distinct gut-to-brain and brain-to-gut syndromes","volume":"49","author":"Keightley","year":"2015","journal-title":"Aust N Z J Psychiatry"},{"key":"10.3233\/JPD-212707_ref146","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/MIB.0000000000000750","article-title":"Current understanding of dysbiosis in disease in human and animal models","volume":"22","author":"DeGruttola","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.3233\/JPD-212707_ref147","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3109\/00207454.2015.1096271","article-title":"Potential role of gut microbiota and tissue barriers in Parkinson\u2019s disease and amyotrophic lateral sclerosis","volume":"126","author":"Fang","year":"2016","journal-title":"Int J Neurosci"},{"key":"10.3233\/JPD-212707_ref148","doi-asserted-by":"crossref","first-page":"e0187307","DOI":"10.1371\/journal.pone.0187307","article-title":"Progression of Parkinson\u2019s disease is associated with gut dysbiosis: Two-year follow-up study","volume":"12","author":"Minato","year":"2017","journal-title":"PLoS One"},{"key":"10.3233\/JPD-212707_ref149","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/mds.26307","article-title":"Colonic bacterial composition in Parkinson\u2019s disease","volume":"30","author":"Keshavarzian","year":"2015","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-212707_ref150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13073-017-0428-y","article-title":"Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naive Parkinson\u2019s disease patients","volume":"9","author":"Bedarf","year":"2017","journal-title":"Genome Med"},{"key":"10.3233\/JPD-212707_ref151","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/mds.26069","article-title":"Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype","volume":"30","author":"Scheperjans","year":"2015","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-212707_ref152","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","article-title":"Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls","volume":"32","author":"Unger","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-212707_ref153","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fnmol.2019.00171","article-title":"Gut microbiota differs between Parkinson\u2019s disease patients and healthy controls in Northeast China","volume":"12","author":"Li","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"10.3233\/JPD-212707_ref154","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.parkreldis.2020.10.034","article-title":"Altered gut microbiota in Parkinson\u2019s disease patients\/healthy spouses and its association with clinical features","volume":"81","author":"Zhang","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-212707_ref155","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.parkreldis.2014.02.019","article-title":"Small intestinal bacterial overgrowth in Parkinson\u2019s disease","volume":"20","author":"Tan","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-212707_ref156","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s00702-016-1612-8","article-title":"Prevalence of small intestinal bacterial overgrowth in Chinese patients with Parkinson\u2019s disease","volume":"123","author":"Niu","year":"2016","journal-title":"J Neural Transm (Vienna)"},{"key":"10.3233\/JPD-212707_ref157","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.parkreldis.2015.02.004","article-title":"Increased urinary indoxyl sulfate (indican): New insights into gut dysbiosis in Parkinson\u2019s disease","volume":"21","author":"Cassani","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-212707_ref158","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5056\/jnm17105","article-title":"Gut microbiota dysfunction as reliable non-invasive early diagnostic biomarkers in the pathophysiology of Parkinson\u2019s disease: A critical review","volume":"24","author":"Nair","year":"2018","journal-title":"J Neurogastroenterol Motil"},{"key":"10.3233\/JPD-212707_ref159","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s10517-017-3700-7","article-title":"Analysis of gut microbiota in patients with Parkinson\u2019s disease","volume":"162","author":"Petrov","year":"2017","journal-title":"Bull Exp Biol Med"},{"key":"10.3233\/JPD-212707_ref160","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3390\/nu10060708","article-title":"Changes of colonic bacterial composition in Parkinson\u2019s disease and other neurodegenerative diseases","volume":"10","author":"Gerhardt","year":"2018","journal-title":"Nutrients"},{"key":"10.3233\/JPD-212707_ref161","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.3389\/fmicb.2019.02305","article-title":"Microbial metabolic capacity for intestinal folate production and modulation of host folate receptors","volume":"10","author":"Engevik","year":"2019","journal-title":"Front Microbiol"},{"key":"10.3233\/JPD-212707_ref162","doi-asserted-by":"crossref","first-page":"e2000426","DOI":"10.1002\/mnfr.202000426","article-title":"Functional roles of B-vitamins in the gut and gut microbiome","volume":"64","author":"Uebanso","year":"2020","journal-title":"Mol Nutr Food Res"},{"key":"10.3233\/JPD-212707_ref163","doi-asserted-by":"crossref","first-page":"14057","DOI":"10.1523\/JNEUROSCI.3890-09.2009","article-title":"Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism","volume":"29","author":"Andrews","year":"2009","journal-title":"J Neurosci"},{"key":"10.3233\/JPD-212707_ref164","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/glycob\/cwt045","article-title":"Mucin-type O-glycans and their roles in intestinal homeostasis","volume":"23","author":"Bergstrom","year":"2013","journal-title":"Glycobiology"},{"key":"10.3233\/JPD-212707_ref165","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/mds.27105","article-title":"The nasal and gut microbiome in Parkinson\u2019s disease and idiopathic rapid eye movement sleep behavior disorder","volume":"33","author":"Heintz-Buschart","year":"2018","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-212707_ref166","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1212\/WNL.0000000000003838","article-title":"Predictive markers for early conversion of iRBD to neurodegenerative synucleinopathy diseases","volume":"88","author":"Li","year":"2017","journal-title":"Neurology"},{"key":"10.3233\/JPD-212707_ref167","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40168-016-0202-1","article-title":"Unusual sub-genus associations of faecal Prevotella and Bacteroides with specific dietary patterns","volume":"4","author":"De Filippis","year":"2016","journal-title":"Microbiome"},{"key":"10.3233\/JPD-212707_ref168","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/MCO.0b013e328365b9be","article-title":"Ghrelin: Much more than a hunger hormone","volume":"16","author":"Pradhan","year":"2013","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.3233\/JPD-212707_ref169","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fmed.2019.00019","article-title":"Gut microbiota and chronic constipation: A review and update","volume":"6","author":"Ohkusa","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"10.3233\/JPD-212707_ref170","first-page":"117","article-title":"Use of probiotics for the treatment of constipation in Parkinson\u2019s disease patients","volume":"57","author":"Cassani","year":"2011","journal-title":"Minerva Gastroenterol Dietol"},{"key":"10.3233\/JPD-212707_ref171","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/gut.52.10.1442","article-title":"Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts","volume":"52","author":"Willemsen","year":"2003","journal-title":"Gut"},{"key":"10.3233\/JPD-212707_ref172","first-page":"295","article-title":"Butyric acid in functional constipation","volume":"8","author":"Pituch","year":"2013","journal-title":"Prz Gastroenterol"},{"key":"10.3233\/JPD-212707_ref173","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fendo.2020.00025","article-title":"The role of short-chain fatty acids from gut microbiota in gut-brain communication","volume":"11","author":"Silva","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.3233\/JPD-212707_ref174","first-page":"81","article-title":"New insight into butyrate metabolism","volume":"62","author":"Bach Knudsen","year":"2003","journal-title":"Soc"},{"key":"10.3233\/JPD-212707_ref175","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.neuroscience.2013.04.037","article-title":"Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced Drosophila model of Parkinson\u2019s disease","volume":"246","author":"St Laurent","year":"2013","journal-title":"Neuroscience"},{"key":"10.3233\/JPD-212707_ref176","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1073\/pnas.1219451110","article-title":"Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity","volume":"110","author":"Everard","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JPD-212707_ref177","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/npjbiofilms.2015.5","article-title":"Microbial biofilms and the human intestinal microbiome","volume":"1","author":"de Vos","year":"2015","journal-title":"NPJ Biofilms Microbiomes"},{"key":"10.3233\/JPD-212707_ref178","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/microorganisms6030075","article-title":"Akkermansia muciniphila in the human gastrointestinal tract: When, where, and how?","volume":"6","author":"Geerlings","year":"2018","journal-title":"Microorganisms"},{"key":"10.3233\/JPD-212707_ref179","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1046\/j.1365-2036.2000.00815.x","article-title":"Parkinsonism: Differential age-trend in Helicobacter pylori antibody","volume":"14","author":"Dobbs","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.3233\/JPD-212707_ref180","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3988\/jcn.2016.12.2.147","article-title":"Association between Parkinson\u2019s disease and Helicobacter pylori","volume":"12","author":"Camci","year":"2016","journal-title":"J Clin Neurol"},{"key":"10.3233\/JPD-212707_ref181","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.parkreldis.2014.12.009","article-title":"Helicobacter pylori infection is associated with worse severity of Parkinson\u2019s disease","volume":"21","author":"Tan","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-212707_ref182","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1523-5378.2005.00329.x","article-title":"Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 3: Predicted probability and gradients of severity of idiopathic parkinsonism based on H. pylori antibody profile","volume":"10","author":"Weller","year":"2005","journal-title":"Helicobacter"},{"key":"10.3233\/JPD-212707_ref183","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1523-5378.2005.00330.x","article-title":"Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 2: Response of facets of clinical idiopathic parkinsonism to Helicobacter pylori eradication. A randomized, double-blind, placebo-controlled efficacy study","volume":"10","author":"Bjarnason","year":"2005","journal-title":"Helicobacter"},{"key":"10.3233\/JPD-212707_ref184","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1757-4749-4-12","article-title":"Leukocyte-subset counts in idiopathic parkinsonism provide clues to a pathogenic pathway involving small intestinal bacterial overgrowth. A surveillance study","volume":"4","author":"Dobbs","year":"2012","journal-title":"Gut Pathog"},{"key":"10.3233\/JPD-212707_ref185","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.mehy.2004.12.033","article-title":"Cycad toxins, Helicobacter pylori and parkinsonism: Cholesterol glucosides as the common denomenator","volume":"66","author":"Schulz","year":"2006","journal-title":"Med Hypotheses"},{"key":"10.3233\/JPD-212707_ref186","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1523-5378.2008.00622.x","article-title":"Helicobacter hypothesis for idiopathic parkinsonism: Before and beyond","volume":"13","author":"Dobbs","year":"2008","journal-title":"Helicobacter"},{"key":"10.3233\/JPD-212707_ref187","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1111\/j.1468-1331.2012.03695.x","article-title":"Helicobacter pylori infection and Parkinson\u2019s disease: Apoptosis as an underlying common contributor","volume":"19","author":"Kountouras","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.3233\/JPD-212707_ref188","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13099-021-00420-w","article-title":"Association of small intestinal bacterial overgrowth with Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"13","author":"Li","year":"2021","journal-title":"Gut Pathog"},{"key":"10.3233\/JPD-212707_ref189","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/mds.25522","article-title":"The role of small intestinal bacterial overgrowth in Parkinson\u2019s disease","volume":"28","author":"Fasano","year":"2013","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-212707_ref190","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ana.25788","article-title":"Gut microbiome signatures of risk and prodromal markers of Parkinson disease","volume":"88","author":"Heinzel","year":"2020","journal-title":"Ann Neurol"}],"container-title":["Journal of Parkinson's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JPD-212707","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:50:23Z","timestamp":1777611023000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JPD-212707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,12]]},"references-count":190,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jpd-212707","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,12]]}}}